Buy Regulus Therapeutics Stock | RGLS Stock Price & Latest News | Public
RGLS

Regulus Therapeutics

$0.00 (0.00%)Today
    Small Market Cap

    About RGLS

    Regulus Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development. RG-012 is an anti-miR targeting miR-21 in Phase II ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.08
    -0.17
    -0.25
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.21

    Actual EPS
    Q3 2020

    Stats

    Market Cap$19,69M
    Volume2,25k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$1.74
    1 Year Low$0.42
    Open$0.57
    High$0.58
    Low$0.56

    Buy any stock with any amount of money.

    Download the App
    Download the app